Biopharma Pharma Specialization Training 
Pharmaceutical Technology
SEPTEMBER 8, 2022
Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. Speciality pharmacies provide comprehensive medications for individuals with serious medical conditions requiring complex treatments, including cancer, cystic fibrosis, haemophilia, hepatitis, HIV, and others.
European Pharmaceutical Review
JUNE 8, 2023
A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation. This has spiked from 27 in 2019 to 225 in 2022.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
MARCH 22, 2023
The appeal of process intensification continues to grow in the biopharma industry as a means of not only increasing the productivity, but also improving sustainability. Chromatography and clarification play vital parts in biopharma manufacturing, yet there is room for improvement in processes to eliminate inefficiencies and increase yield.
Pharma Marketing Network
MARCH 25, 2022
5 While the CDC gathers information on these topics for public health planning, there are immediate needs that pharma can address. . What Can Pharma Do? Including caregiver insights and creating specific caregiver materials in the product development cycle is a good place for pharma to engage caregivers. Sunny White.
PM360
JUNE 30, 2022
Inizio Advisory: This unit helps pharma, biotech, and life sciences companies to develop, execute, and operationalize their strategies across portfolio licensing and development, new product launches, established product and franchise strategy, HEOR, pricing, and market access. Inizio launches with five specialist business units: 1.
European Pharmaceutical Review
FEBRUARY 21, 2023
Hiring a good team is paramount – as is training and development. How do you see the evolution of cannabis-based medicines, particularly when it comes to the ‘specials’ or fully licensed drug routes? We are already seeing rapid growth in the UK ‘specials’ market for a variety of conditions, with some very positive patient outcomes.
Pharmaceutical Technology
MAY 24, 2023
Every major pharma company is now involved in CGT development which has resulted in the approval of 28 therapies by the FDA thereby making CGT no longer a niche category of therapies. CGT have highly unique and specialized manufacturing processes. This is a primary factor for the staggeringly high unit cost of CGT.
Expert insights. Personalized for you.
45 
Let's personalize your content